Technical Analysis for GTHX - G1 Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 38.93 1.38% 0.53
GTHX closed up 1.38 percent on Friday, April 20, 2018, on 31 percent of normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical GTHX trend table...

Date Alert Name Type % Chg
Apr 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Apr 18 Multiple of Ten Bearish Other 0.18%
Apr 18 Inside Day Range Contraction 0.18%
Apr 17 New Uptrend Bullish -4.30%
Apr 17 Multiple of Ten Bullish Other -4.30%
Apr 17 Wide Bands Range Expansion -4.30%
Apr 17 Overbought Stochastic Strength -4.30%
Apr 16 NR7 Range Contraction 7.27%
Apr 16 NR7-2 Range Contraction 7.27%
Apr 16 Wide Bands Range Expansion 7.27%

Older signals for GTHX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
G1 Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38 are designed to be combined and enhance the anti-tumor activity of current therapies. It is also developing G1T48, an oral selective estrogen receptor degrader (SERD) for the treatment of breast cancer. The Company is evaluating trilaciclib in three Phase II clinical trials. G1T38 is being evaluated in combination with Faslodex in a Phase I b/II a trial for patients with estrogen receptor-positive, HER2-negative breast cancer.
Is GTHX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 42.776
52 Week Low 12.04
Average Volume 273,304
200-Day Moving Average 23.3447
50-Day Moving Average 31.7036
20-Day Moving Average 37.5395
10-Day Moving Average 37.36
Average True Range 2.648
ADX 25.93
+DI 23.29
-DI 16.39
Chandelier Exit (Long, 3 ATRs ) 34.832
Chandelier Exit (Short, 3 ATRs ) 42.604
Upper Bollinger Band 41.0323
Lower Bollinger Band 34.0467
Percent B (%b) 0.7
BandWidth 18.608666
MACD Line 1.4437
MACD Signal Line 1.6154
MACD Histogram -0.1716
Fundamentals Value
Market Cap 1.1 Billion
Num Shares 28.3 Million
EPS -11.02
Price-to-Earnings (P/E) Ratio -3.53
Price-to-Sales 0.00
Price-to-Book 4.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.30
Resistance 3 (R3) 43.93 41.76 43.41
Resistance 2 (R2) 41.76 40.40 41.95 43.11
Resistance 1 (R1) 40.35 39.55 41.06 40.72 42.81
Pivot Point 38.18 38.18 38.54 38.37 38.18
Support 1 (S1) 36.77 36.82 37.48 37.14 35.05
Support 2 (S2) 34.60 35.97 34.79 34.75
Support 3 (S3) 33.19 34.60 34.46
Support 4 (S4) 33.56